These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16856974)

  • 1. A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests.
    Budd R; Harley E; Quarshie A; Henderson V; Harris EN; Pierangeli SS
    J Thromb Haemost; 2006 Oct; 4(10):2210-4. PubMed ID: 16856974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
    Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off levels based on deviation from standard negative control is better than moderate level based on fixed cut-off for ACA assessed using ELISA for the diagnosis of antiphospholipid syndrome.
    Effendy S; Tambunan KL; Reksodiputro AH
    Acta Med Indones; 2005; 37(1):12-9. PubMed ID: 15879633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical laboratory testing for the antiphospholipid syndrome.
    Pierangeli SS; Harris EN
    Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction for age of anticardiolipin antibodies cut-off points.
    Rapizzi E; Ruffatti A; Tonello M; Piccoli A; Calligaro A; Sfriso P; Todesco S
    J Clin Lab Anal; 2000; 14(3):87-90. PubMed ID: 10797605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.
    Zhang S; Wu Z; Li P; Bai Y; Zhang F; Li Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2059. PubMed ID: 26579816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies.
    Amengual O; Horita T; Binder W; Norman GL; Shums Z; Kato M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Atsumi T
    Rheumatol Int; 2014 Sep; 34(9):1225-30. PubMed ID: 24497039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines.
    Bor MV; Jacobsen IS; Gram JB; Sidelmann JJ
    Lupus; 2018 Aug; 27(9):1446-1454. PubMed ID: 29848159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.
    Zuo Y; Willis R; Papalardo E; Petri M; Harris EN; Schleh A; DeCeulaer K; Smikle M; Vilá LM; Reveille JD; Alarcón GS; Gonzalez EB
    Lupus; 2017 May; 26(6):606-615. PubMed ID: 27753626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
    Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
    J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An automated chemiluminescence immunoassay may detect mostly relevant IgG anticardiolipin antibodies according to revised Sydney criteria.
    Noubouossie D; Valsamis J; Corazza F; Rozen L; Debaugnies F; Demulder A
    Acta Clin Belg; 2012; 67(3):184-9. PubMed ID: 22897066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.